Moro Alessandro, De Angelis Paolo, Gasparini Giulio, Pelo Sandro, Petrone Gianluigi, Lucci Cordisco Emanuela, Garagiola Umberto, D'Amato Giuseppe, Saponaro Gianmarco
Department of Oral and Maxillofacial Surgery, Catholic University of the Sacred Heart Medical School, Rome, Italy.
Department of Histopathology and Cytopathology, Catholic University of the Sacred Heart Medical School, Rome, Italy.
Case Rep Oncol Med. 2018 Mar 8;2018:1684763. doi: 10.1155/2018/1684763. eCollection 2018.
Desmoid-type fibromatosis is a benign fibrous neoplasia originating from connective tissue, fascial planes, and musculoaponeurotic structures of the muscles. Currently, there is no evidence-based treatment approach available for desmoid fibromatosis. In this article, a case of a patient in the pediatric age affected by desmoid fibromatosis localized in the orbit is presented. The aim of the article is to describe this unusual and rare location for the desmoid fibromatosis and outline the principle phases in the decision-making process and the therapeutic alternatives for a patient affected by desmoid fibromatosis.
The protocol of this review included study objectives, search strategy, and selection criteria. The primary end point of this study was to analyze the head and neck desmoid fibromatosis. The secondary end point was to identify the available therapies and assess their specific indications.
The mean age of patients was 18.9 years ranging from 0 to 66, and 52% were female. A bimodal age distribution was observed, and two age peaks were identified: 0-14 years (57%) and 28-42 years (18%). The most common involved areas were the mandible (25%) followed by the neck (21%). In 86% of the cases, the treatment was the surgical resection of the disease, and only in 5% of the cases, the surgical resection was followed by adjuvant radiotherapy.
The orbital location is extremely rare, especially in the pediatric population. The management of desmoid fibromatosis is based on the function preservation and the maintenance of a good quality of life, but in case of symptomatic patients or aggressive course of the disease or risk of functional damages, the surgical approach may be considered. Therapeutic alternatives to surgical resection are radiotherapy and systemic therapy.
韧带样型纤维瘤病是一种起源于结缔组织、筋膜平面和肌肉的肌筋膜结构的良性纤维性肿瘤。目前,对于韧带样纤维瘤病尚无循证治疗方法。本文介绍了一例患有眼眶韧带样纤维瘤病的儿科患者。本文的目的是描述韧带样纤维瘤病这种不寻常且罕见的发病部位,并概述决策过程中的主要阶段以及韧带样纤维瘤病患者的治疗选择。
本综述方案包括研究目的、检索策略和选择标准。本研究的主要终点是分析头颈部韧带样纤维瘤病。次要终点是确定可用的治疗方法并评估其具体适应症。
患者的平均年龄为18.9岁,范围从0岁至66岁,52%为女性。观察到双峰年龄分布,并确定了两个年龄高峰:0 - 14岁(57%)和28 - 42岁(18%)。最常受累的部位是下颌骨(25%),其次是颈部(21%)。在86%的病例中,治疗方法是对病变进行手术切除,仅5%的病例在手术切除后进行辅助放疗。
眼眶发病部位极为罕见,尤其是在儿科人群中。韧带样纤维瘤病的治疗基于功能保留和维持良好的生活质量,但对于有症状的患者、疾病进展迅速或有功能损害风险的情况,可考虑采用手术方法。手术切除的替代治疗方法是放疗和全身治疗。